Sign Up to like & get
recommendations!
0
Published in 2020 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000815
Abstract: BACKGROUND Aprepitant, an antiemetic selective neurokinin-1 receptor antagonist, is primarily metabolized to the active N-dealkylated (ND-AP) form and then converted to its carbonyl (ND-CAP) form in humans. This study developed simple liquid chromatography-tandem mass spectrometry…
read more here.
Keywords:
dealkylated metabolites;
active dealkylated;
aprepitant;
total free ... See more keywords